Xin-Yue Yang Selected Research

Edema (Dropsy)

4/2020

Ulinastatin ameliorates acute kidney injury induced by crush syndrome inflammation by modulating Th17/Treg cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin-Yue Yang Research Topics

Disease

4	Hypoxia (Hypoxemia) 01/2024 - 01/2021
3	Inflammation (Inflammations) 01/2024 - 04/2020
2	Osteoporosis 03/2024 - 10/2023
2	Rectal Neoplasms (Rectal Cancer) 10/2023 - 09/2023
1	Breast Neoplasms (Breast Cancer) 03/2024
1	COVID-19 01/2024
1	Neuroinflammatory Diseases 01/2024
1	Iron Overload 01/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2023
1	Hypertriglyceridemia 11/2023
1	Insulin Resistance 11/2023
1	Neoplasms (Cancer) 10/2023
1	Extranodal Extension 10/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Obesity 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Mpox (monkeypox) 01/2022
1	Cognitive Dysfunction 01/2021
1	Obstructive Sleep Apnea 01/2021
1	Edema (Dropsy) 04/2020
1	Acute Kidney Injury (Acute Renal Failure) 04/2020
1	Sepsis (Septicemia) 04/2020
1	Rupture 04/2020
1	Crush Syndrome 04/2020

Drug/Important Bio-Agent (IBA)

3	IronIBA 01/2024 - 01/2021
2	LactonesIBA 03/2024 - 10/2023
2	Banxia Houpo TangIBA 01/2024 - 12/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 01/2021
1	2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA 03/2024
1	VaccinesIBA 01/2024
1	GlycolipidsIBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	FructoseIBA 11/2023
1	AlkaloidsIBA 10/2023
1	2,3-bis(3'-hydroxybenzyl)butane-1,4-diol (enterodiol)IBA 10/2023
1	N-feruloylserotoninIBA 10/2023
1	AlloxanIBA 10/2023
1	GlucosidesIBA 10/2023
1	LignansIBA 10/2023
1	tyramine-deoxysorbitolIBA 10/2023
1	huperzine AIBA 01/2023
1	Liposomes (Liposome)IBA 01/2023
1	Liraglutide FDA Link 01/2022
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	HepcidinsIBA 01/2021
1	MyoglobinIBA 04/2020
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 04/2020
1	urinastatin (MR 20)IBA 04/2020

Therapy/Procedure

2	Neoadjuvant Therapy 10/2023 - 09/2023
2	Therapeutics 10/2023 - 01/2023
1	Consolidation Chemotherapy 10/2023